Article Versions Notes

Ingrasciotta Y, Fontana A, Mancuso A, Ientile V, Sultana J, Uomo I, Pastorello M, Calabrò P, Andò G, Trifirò G. Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy. Pharmaceuticals. 2021; 14(4):290. https://doi.org/10.3390/ph14040290

Ingrasciotta, Ylenia, Andrea Fontana, Anna Mancuso, Valentina Ientile, Janet Sultana, Ilaria Uomo, Maurizio Pastorello, Paolo Calabrò, Giuseppe Andò, and Gianluca Trifirò. 2021. "Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy" Pharmaceuticals 14, no. 4: 290. https://doi.org/10.3390/ph14040290

Ingrasciotta, Y., Fontana, A., Mancuso, A., Ientile, V., Sultana, J., Uomo, I., Pastorello, M., Calabrò, P., Andò, G., & Trifirò, G. (2021). Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy. Pharmaceuticals, 14(4), 290. https://doi.org/10.3390/ph14040290